JP2002234843A5 - - Google Patents

Download PDF

Info

Publication number
JP2002234843A5
JP2002234843A5 JP2001375062A JP2001375062A JP2002234843A5 JP 2002234843 A5 JP2002234843 A5 JP 2002234843A5 JP 2001375062 A JP2001375062 A JP 2001375062A JP 2001375062 A JP2001375062 A JP 2001375062A JP 2002234843 A5 JP2002234843 A5 JP 2002234843A5
Authority
JP
Japan
Prior art keywords
group
alkyl
aralkyl
substituent
carbamoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001375062A
Other languages
Japanese (ja)
Other versions
JP4160295B2 (en
JP2002234843A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2001375062A priority Critical patent/JP4160295B2/en
Priority claimed from JP2001375062A external-priority patent/JP4160295B2/en
Publication of JP2002234843A publication Critical patent/JP2002234843A/en
Publication of JP2002234843A5 publication Critical patent/JP2002234843A5/ja
Application granted granted Critical
Publication of JP4160295B2 publication Critical patent/JP4160295B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Description

実施例15
4-[2-[4-(トリフルオロメチル)ピリジン-3-イル]-1,3-チアゾール-4-イル]アニリン (156)
化合物(59)(0.61 g, 1.72 mmol)をギ酸(10 ml)に溶解し、Pd-C(0.06 g, 10 wt.%)を加え、水素雰囲気下常温常圧で2時間撹拌した。触媒等を濾去した後、ギ酸を減圧濃縮し、残さを酢酸エチルと飽和重曹水で分配した。有機層を食塩水で洗浄後、乾燥(MgSO4)し、溶媒を減圧下に留去した。得られた残渣をシリカゲルカラムクロマトグラフィーで精製して白色結晶(0.23 g, 42 %)を得た。
融点 71-72 ℃
元素分析値C15H10N 3 SF3として
C(%) H(%) N(%)
計算値:56.07;3.14 ;13.08
実測値:56.08;3.09 ;13.12
1H-NMR (200Hz, CDCl3) δ : 3.80 (2H, s), 6.76 (2H, d, J = 8.8 Hz), 7.48 (1H, s), 7.70 (1H, d, J = 5.2 Hz), 7.77 (2H, d, J = 8.8 Hz), 8.87 (1H, d, J = 5.2 Hz), 9.05 (1H, s)
Example 15
4- [2- [4- (Trifluoromethyl) pyridin-3-yl] -1,3-thiazol-4-yl] aniline (156)
Compound (59) (0.61 g, 1.72 mmol) was dissolved in formic acid (10 ml), Pd-C (0.06 g, 10 wt.%) Was added, and the mixture was stirred under hydrogen atmosphere at normal temperature and pressure for 2 hours. After removing the catalyst and the like by filtration, formic acid was concentrated under reduced pressure, and the residue was partitioned between ethyl acetate and saturated aqueous sodium bicarbonate. The organic layer was washed with brine, dried (MgSO 4 ) and the solvent was evaporated under reduced pressure. The obtained residue was purified by silica gel column chromatography to obtain white crystals (0.23 g, 42%).
Melting point 71-72 ° C
Elemental analysis value C 15 H 10 N 3 S F 3
C (%) H (%) N (%)
Calculated value: 56.07; 3.14; 13.08
Found: 56.08; 3.09; 13.12
1 H-NMR (200 Hz, CDCl 3 ) δ: 3.80 (2 H, s), 6. 76 (2 H, d, J = 8.8 Hz), 7. 48 (1 H, s), 7. 70 (1 H, d, J = 5.2 Hz), 7.77 (2H, d, J = 8.8 Hz), 8.87 (1 H, d, J = 5.2 Hz), 9.05 (1 H, s)

実施例16
3-[2-[4-(トリフルオロメチル)ピリジン-3-イル]-1,3-チアゾール-4-イル]アニリン (157)
実施例15に記載した方法と同様にして化合物(60)(1.00 g, 2.85 mmol)から無色アモルファス(0.94 g, quant.)を得た。
元素分析値C15H10N 3 SF3として
C(%) H(%) N(%)
計算値:56.07;3.14 ;13.08
実測値:56.00;3.23 ;13.02
1H-NMR (200Hz, CDCl3) δ : 3.64 (2H, s), 6.71 (1H, d, J = 7.6 Hz), 7.19-7.35 (3H, m), 7.65 (1H, s), 7.70 (1H, d, J = 5.2 Hz), 8.88 (1H, d, J = 5.2 Hz), 9.04 (1H, s)
Example 16
3- [2- [4- (Trifluoromethyl) pyridin-3-yl] -1,3-thiazol-4-yl] aniline (157)
A colorless amorphous (0.94 g, quant.) Was obtained from compound (60) (1.00 g, 2.85 mmol) in the same manner as the method described in Example 15.
Elemental analysis value C 15 H 10 N 3 S F 3
C (%) H (%) N (%)
Calculated value: 56.07; 3.14; 13.08
Found: 56.00; 3.23; 13.02
1 H-NMR (200 Hz, CDCl 3 ) δ: 3.64 (2 H, s), 6.71 (1 H, d, J = 7.6 Hz), 7.19-7.35 (3 H, m), 7.65 (1 H, s), 7.70 (1 H , d, J = 5.2 Hz), 8. 88 (1 H, d, J = 5.2 Hz), 9.04 (1 H, s)

実施例18
N-(3-[2-[4-(トリフルオロメチル)ピリジン-3-イル]-1,3-チアゾール-4-イル]フェニル)アセトアミド塩酸塩 (159)
実施例17に記載した方法と同様にして化合物(157)(0.38 g, 1.18 mmol)から無色アモルファス(0.30 g, 70 %)を得た。このアモルファスのメタノール(3 ml)溶液に氷冷下、4N酢酸エチル性塩酸(0.22 ml)を加え同温で10分間撹拌した。反応液を減圧下濃縮して得られた残渣を酢酸エチル−メタノールから結晶化させて塩酸塩を黄色針状晶として得た。
融点 154-155 ℃
元素分析値C17H12N3OSF3・HCl・0.1H2Oとして
C(%) H(%) N(%)
計算値:50.84;3.31 ;10.45
実測値:50.76;3.54 ;10.36
1H-NMR (200Hz, CDCl3) δ : 2.21 (3H, s), 7.38-7.46 (2H, m), 7.62-7.74 (4H, m), 8.06 (1H, s), 8.90 (1H, d, J = 4.8 Hz), 9.05 (1H, s)
Example 18
N- (3- [2- [4- (Trifluoromethyl) pyridin-3-yl] -1,3-thiazol-4-yl] phenyl) acetamide hydrochloride (159)
A colorless amorphous (0.30 g, 70%) was obtained from compound (157) (0.38 g, 1.18 mmol) in the same manner as the method described in Example 17. Under ice-cooling, 4N ethyl acetate hydrochloric acid (0.22 ml) was added to a solution of this amorphous methanol (3 ml) and stirred at the same temperature for 10 minutes. The reaction mixture was concentrated under reduced pressure, and the obtained residue was crystallized from ethyl acetate-methanol to give hydrochloride as yellow needles.
Melting point 154-155 ° C
Elemental analysis value C 17 H 12 N 3 OSF 3 · HCl · 0.1 H 2 O
C (%) H (%) N (%)
Calculated value: 50.84; 3.31; 10.45
Found: 50.76; 3.54; 10.36
1 H-NMR (200 Hz, CDCl 3 ) δ: 2.21 (3 H, s), 7.38-7.46 (2 H, m), 7.62-7.64 (4 H, m), 8.06 (1 H, s), 8. 90 (1 H, d, J = 4.8 Hz), 9.05 (1 H, s)

実施例19
N-(4-[2-[4-(トリフルオロメチル)ピリジン-3-イル]-1,3-チアゾール-4-イル]フェニル)メタンスルホンアミド塩酸塩 (160)
実施例17に記載した方法と同様にしてアセチルクロリドのかわりにメタンスルホニルクロリドを用い、化合物(156)(0.28 g, 0.87mmol)から無色アモルファス(0.25 g, 72 %)を得た。このアモルファスのメタノール(3 ml)溶液に氷冷下、4N酢酸エチル性塩酸(0.16 ml)を加え同温で10分間撹拌した。反応液を減圧下濃縮して得られた残渣を酢酸エチル−メタノールから結晶化させて塩酸塩を黄色結晶として得た。
融点 205-207 ℃
元素分析値C16H12N3O2S2F3・HClとして
C(%) H(%) N(%)
計算値:44.09;3.01 ;9.64
実測値:44.07;2.97 ;9.69
1H-NMR (200Hz, CDCl3) δ : 3.06 (3H, s), 6.45 (1H, s), 7.31 (2H, d, J = 8.8 Hz), 7.67 (1H, s), 7.73 (1H, d, J = 4.8 Hz), 7.98 (2H, d, J = 8.8 Hz), 8.91 (1H, d, J = 4.8 Hz), 9.06 (1H, s)
Example 19
N- (4- [2- [4- (Trifluoromethyl) pyridin-3-yl] -1,3-thiazol-4-yl] phenyl) methanesulfonamide hydrochloride (160)
A colorless amorphous (0.25 g, 72%) was obtained from compound (156) (0.28 g, 0.87 mmol) using methanesulfonyl chloride instead of acetyl chloride in the same manner as described in Example 17. Under ice-cooling, 4N ethyl acetate hydrochloric acid (0.16 ml) was added to a solution of this amorphous methanol (3 ml) and stirred at the same temperature for 10 minutes. The reaction mixture was concentrated under reduced pressure, and the obtained residue was crystallized from ethyl acetate-methanol to give hydrochloride as yellow crystals.
Melting point 205-207 ° C
Elemental analysis value C 16 H 12 N 3 O 2 S 2 F 3 · HCl
C (%) H (%) N (%)
Calculated value: 44.09; 3.01; 9.64
Found: 44.07; 2.97; 9.69
1 H-NMR (200 Hz, CDCl 3 ) δ: 3.06 (3 H, s), 6.45 (1 H, s), 7.31 (2 H, d, J = 8.8 Hz), 7.67 (1 H, s), 7.73 (1 H, d , J = 4.8 Hz), 7.98 (2 H, d, J = 8.8 Hz), 8. 91 (1 H, d, J = 4.8 Hz), 9.06 (1 H, s)

実施例20
N-(3-[2-[4-(トリフルオロメチル)ピリジン-3-イル]-1,3-チアゾール-4-イル]フェニル)メタンスルホンアミド塩酸塩 (161)
実施例17に記載した方法と同様にしてアセチルクロリドのかわりにメタンスルホニルクロリドを用い、化合物(157)(0.31 g, 0.96 mmol)から無色アモルファス(0.28 g, 70 %)を得た。このアモルファスの酢酸エチル(2 ml)溶液に氷冷下、4N酢酸エチル性塩酸(0.18 ml)を加え同温で10分間撹拌した。反応液を減圧下濃縮して得られた残渣を酢酸エチルから結晶化させて塩酸塩を黄色結晶として得た。
融点 162-165 ℃
元素分析値C16H12N3O2S2F3・HClとして
C(%) H(%) N(%)
計算値:44.09;3.01 ;9.64
実測値:44.02;2.28 ;9.63
1H-NMR (200Hz, CDCl3) δ : 3.06 (3H, s), 6.66 (1H, s), 7.27-7.42 (1H, m), 7.46 (1H, t, J = 7.9 Hz), 7.72-7.84 (4H, m), 8.91 (1H, d, J = 5.6 Hz), 9.05 (1H, s)
Example 20
N- (3- [2- [4- (trifluoromethyl) pyridin-3-yl] -1,3-thiazol-4-yl] phenyl) methanesulfonamide hydrochloride (161)
A colorless amorphous (0.28 g, 70%) was obtained from compound (157) (0.31 g, 0.96 mmol) using methanesulfonyl chloride instead of acetyl chloride in the same manner as described in Example 17. To this amorphous ethyl acetate (2 ml) solution was added 4N ethyl acetate hydrochloric acid (0.18 ml) under ice cooling, and the mixture was stirred at the same temperature for 10 minutes. The reaction solution was concentrated under reduced pressure, and the obtained residue was crystallized from ethyl acetate to give hydrochloride as yellow crystals.
Melting point 162-165 ° C
Elemental analysis value C 16 H 12 N 3 O 2 S 2 F 3 · HCl
C (%) H (%) N (%)
Calculated value: 44.09; 3.01; 9.64
Found: 44.02; 2.28; 9.63
1 H-NMR (200 Hz, CDCl 3 ) δ: 3.06 (3H, s), 6.66 (1H, s), 7.27-7.42 (1H, m), 7.46 (1H, t, J = 7.9 Hz), 7.72-7.84 (4H, m), 8. 91 (1 H, d, J = 5.6 Hz), 9.05 (1 H, s)

Claims (1)

1cが1)置換基としてC1-4アルキルもしくはC7-9アラルキルを有していてもよいカルバモイル基または2)C1-4アルキルスルホニル基を示すか、または互いに隣接する炭素原子に置換した2個のR1bが結合してC1-2アルキレンジオキシ基を示し、R2aおよびR2bはそれぞれ同一または異なって1)水素原子、2)置換基としてハロゲンまたはヒドロキシを有していてもよいC1-4アルキル、3)カルボキシル基またはC1-4アルコキシカルボニル基、4)置換基としてC1-4アルキルもしくはC7-9アラルキルを有していてもよいカルバモイル基、5)置換基としてC1-4アルキル、カルバモイル−C1-4アルキルまたはC7-10アラルキルを有していてもよいアミノ基、6)ピペリジノ基またはモルホリノ基、7)C1-4アルキルチオ基または8)C1-4アルコキシ基であるか、またはR2aおよびR2b が結合してブタジエニレン基を形成しており、R3が1)水素原子、2)ハロゲン原子、3)C1-4アルキル基または4)カルボキシル基または5)C1-4アルコキシカルボニル基である請求項39記載の化合物。R 1c is 1) a carbamoyl group optionally having C 1-4 alkyl or C 7-9 aralkyl as a substituent, or 2) a C 1-4 alkylsulfonyl group, or substitution at a carbon atom adjacent to each other And two R 1b 's are bonded to each other to represent a C 1-2 alkylenedioxy group, and R 2a and R 2b are the same or different and each has 1) a hydrogen atom and 2) halogen or hydroxy as a substituent C 1-4 alkyl, 3) carboxyl group or C 1-4 alkoxycarbonyl group, 4) carbamoyl group optionally having C 1-4 alkyl or C 7-9 aralkyl as a substituent, 5) substitution Amino group which may have C 1-4 alkyl, carbamoyl-C 1-4 alkyl or C 7-10 aralkyl as a group, 6) piperidino group or morpholino group, 7) C 1-4 alkylthio group or 8) Or a C 1-4 alkoxy group, or R 2a and R 2 b combine to form a butadienylene group, R 3 is 1) a hydrogen atom, 2) a halogen atom, 3) a C 1-4 alkyl group Or 4) a carboxyl group or 5) a C 1-4 alkoxycarbonyl group.
JP2001375062A 2000-12-08 2001-12-07 Substituted thiazole derivatives having a 3-pyridyl group, method for producing the same, and use thereof Expired - Fee Related JP4160295B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001375062A JP4160295B2 (en) 2000-12-08 2001-12-07 Substituted thiazole derivatives having a 3-pyridyl group, method for producing the same, and use thereof

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000373868 2000-12-08
JP2000-373868 2000-12-08
JP2001375062A JP4160295B2 (en) 2000-12-08 2001-12-07 Substituted thiazole derivatives having a 3-pyridyl group, method for producing the same, and use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008154723A Division JP2008266349A (en) 2000-12-08 2008-06-12 Substituted thiazole derivative bearing 3-pyridyl group, method for producing the same and use thereof

Publications (3)

Publication Number Publication Date
JP2002234843A JP2002234843A (en) 2002-08-23
JP2002234843A5 true JP2002234843A5 (en) 2005-05-26
JP4160295B2 JP4160295B2 (en) 2008-10-01

Family

ID=26605479

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001375062A Expired - Fee Related JP4160295B2 (en) 2000-12-08 2001-12-07 Substituted thiazole derivatives having a 3-pyridyl group, method for producing the same, and use thereof

Country Status (1)

Country Link
JP (1) JP4160295B2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003015820A1 (en) * 2001-08-10 2003-02-27 Takeda Chemical Industries, Ltd. GnRH AGONIST COMBINATION DRUGS
JP4731468B2 (en) * 2003-05-12 2011-07-27 ファイザー・プロダクツ・インク Benzamide inhibitor of P2X7 receptor
EP1932833B1 (en) * 2005-10-07 2012-08-01 Kissei Pharmaceutical Co., Ltd. Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
HUE036086T2 (en) 2007-08-13 2018-06-28 Monsanto Technology Llc Compositions and methods for controlling nematodes
JP6267221B2 (en) * 2012-11-16 2018-01-24 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Process for the preparation of 2-trifluoromethylisonicotinic acid and esters
CN111263756B (en) * 2017-07-11 2023-05-16 赛泰尔治疗公司 RAD51 inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9413975D0 (en) * 1994-07-11 1994-08-31 Fujisawa Pharmaceutical Co New heterobicyclic derivatives
KR100195433B1 (en) * 1990-11-30 1999-06-15 오쓰까 아끼히꼬 Active oxygen inhibitor
ES2151652T3 (en) * 1995-02-02 2001-01-01 Smithkline Beecham Plc DERIVATIVES OF INDOL AS ANTAGONISTS OF THE 5HT RECEIVER.
JPH1179993A (en) * 1997-09-05 1999-03-23 Sumitomo Pharmaceut Co Ltd Immunosuppressant
WO2003027096A1 (en) * 2001-09-26 2003-04-03 Bayer Pharmaceuticals Corporation Substituted 3-pyridyl imidazoles as c17,20 lyase inhibitors

Similar Documents

Publication Publication Date Title
JP4634560B2 (en) Process for producing optically active indoline derivative and production intermediate thereof
RU2379289C2 (en) Indoline compound and method of producing said compound
WO2003076405A1 (en) Monocyclic aroylpyridinones as antiinflammatory agents
MA27660A1 (en) HETEROARYLCARBAMOYLBENZENE DERIVATIVE
JP2010510976A (en) Novel process for the preparation of 2-imino-thiazolidin-4-one derivatives
JP2008509896A (en) Method for fluorination of protected aminothiazole
JP2002234843A5 (en)
JP2005529881A (en) 5-[[2 (R)-[1 (R)-[3,5-bis (trifluoromethyl) phenyl] ethoxy] -3 (S)-(4-fluorophenyl) -4-morpholinyl] methyl]- Process for producing 1,2-dihydro-3H-1,2,4-triazol-3-one
JP2003508522A5 (en)
JP3712619B2 (en) Catechol hydrazone derivative, production method and pharmaceutical composition containing the same
JP4323718B2 (en) Method for producing substituted alkylamine or salt thereof
KR19980702282A (en) Process for the preparation of indolin compounds and intermediates for their preparation
JP4023697B2 (en) Method for producing naphthalene derivative
KR20080034948A (en) Chemical process
US20070135434A1 (en) Sulfonyloxy derivatives
JP2004091486A5 (en)
JP3174767B2 (en) Aromatic amidine derivatives useful as selective thrombin inhibitors
JP2006176531A (en) Optical isomer of optically active benzimidazole derivative
JP4194856B2 (en) 2-Phenyl-4- (1-naphthyl) imidazole
JP2002255915A (en) Method for producing midodrine
EP1518856A1 (en) Process for producing quinolonecarboxylic acid derivative
JP2004500413A (en) Method for the selective N-formylation of N-hydroxylamine
WO2017104782A1 (en) Method for manufacturing oxadiazole compound
US20030130326A1 (en) 1,3,4-oxadiazole derivatives and process for producing the same
JP2002053531A (en) Method for producing 2-(5-halogeno-2-nitrophenyl)-2- substituted acetic acid ester derivative